Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients
Abstract: Introduction: Iron-chelating therapy with deferoxamine in patients with thalassemia major has dramatically improved the prognosis of this disease. However, the limitations of this treatment have stimulated the design of alternative orally active iron chelators. Objective: To compare the ef...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , |
| التنسيق: | article |
| منشور في: |
2001
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/3921 http://dx.doi.org/10.1034/j.1600-0609.2001.067001030.x http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://onlinelibrary.wiley.com/doi/10.1034/j.1600-0609.2001.067001030.x/full |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|